Contrast injector developer Acist Medical Systems has opened a new 75,000-sq-ft corporate headquarters and manufacturing facility in Eden Prairie, MN.
The new facility will host R&D departments, engineering laboratories, manufacturing, and technical and customer service, as well as other corporate functions.
Acist Medical Systems, a subsidiary of Milan, Italy-based Bracco, designs, manufactures, and markets a variable-rate contrast injection system for cardiovascular angiography. The company has more than 220 employees worldwide and regional offices in Europe and Asia, including Japan and China.
Related Reading
Acist debuts Cvi, November 18, 2005
Acist launches new contrast injector, October 18, 2005
Bracco to acquire injector firm Acist, June 20, 2001
Acist gets FDA nod for Voyager, March 13, 2001
FDA clears Acist contrast injector, June 5, 2000
Copyright © 2008 AuntMinnie.com
![Representative example of a 16-year-old male patient with underlying X-linked adrenoleukodystrophy. (A, B) Paired anteroposterior (AP) chest radiograph and dual-energy x-ray absorptiometry (DXA) report shows lumbar spine (L1 through L4) areal bone mineral density (BMD). The DXA report was reformatted for anonymization and improved readability. The patient had low BMD (Z score ≤ −2.0). (C) Model (chest radiography [CXR]–BMD) output shows the predicted raw BMD and Z score in comparison with the DXA reference standard, together with interpretability analyses using Shapley additive explanations (SHAP) and gradient-weighted class activation maps. The patient was classified as having low BMD, consistent with the reference standard. AM = age-matched, DEXA = dual-energy x-ray absorptiometry, RM2 = room 2, SNUH = Seoul National University Hospital, YA = young adult.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/ai-children-bone-density.0snnf2EJjr.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
